C4 Tx - Wutah bathi EPS kuartalan CCCC

Logo korporat perusahaan C4 Therapeutics (CCCC)

Local conflicts are hindering medical research and disrupting biomaterial logistics for C4 Therapeutics, Inc. (CCCC). Quarterly growth in earnings per share reflects revenue dynamics, where the 63.30 mark captures the latest data. While challenges with Asian raw material imports limit business stability, partnerships with pharma behemoths in the field of protein degradation create a promising foundation for commercial success.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan c4therapeutics.com (CCCC): kanggo periode 04.07.2022 - 16.11.2026

Rincian analitis perusahaan C4 Therapeutics, Inc.

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:c4therapeutics.com - CCCC
Barang unggulan c4therapeutics.com

This indicator measures the dynamics of net earnings per share, reflecting the actual speed of financial result capitalization. For C4 Therapeutics, Inc. (CCCC), this calculation is critical, as a high proportion of R&D expenses creates a sharp contrast with the future profitability of patents. By analyzing the relative growth of quarterly EPS, an investor can see the pace of the transition from losses to superprofits. The metric eliminates price noise, focusing instead on fundamental income. A positive trend would confirm the commercial scalability of the developments.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NUVL (Nuvalent Therapeutics) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan kymeratx.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ORIC (ORIC Pharmaceuticals Inc)|Wutah bathi resik saben saham sajroning taun lumaku Relay Pharma|Nurix Therapeutics Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Tyra Biosciences|VSTM (Verastem, Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|GLUE: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CGEM (cullinanoncology.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Immuneering Inc. IMRX|Wutah bathi EPS kuartalan BDTX|Repare Therapeutics Inc. - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|PMV Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPTI|PPCB: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cyclacel Pharmaceuticals - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|AADI: Wutah bathi EPS kuartalan|Aileron Therapeutics Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|BPMC (Blueprint Medicines Corp.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)